Bellevue Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bellevue Group’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,200	Closed	-$846K	–	166
2023 Q2	$846K	Buy	+18,200	New	+$629K	0.01%	132

Bellevue Group's DICE Position: Q3 2023 in Review

Bellevue Group sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 18,200 shares — an estimated $846K sold.

Bellevue Group first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $846K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Bellevue Group reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bellevue Group sold 18,200 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $846K.
Bellevue Group first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Bellevue Group's DICE Therapeutics, Inc. Common Stock position peaked at $846K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bellevue Group's 13F filing for Q3 2023, filed 14 Nov 2023.